Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

South Korean Health Ministry Hesitant To Punish Doctors For Accepting Pharma Rebates

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korea's Ministry for Health, Welfare and Family Affairs denied a string of pharma industry expectations and local press reports that it was moving to tighten legal restrictions and punishments for doctors who accept rebates from pharmaceutical companies

You may also be interested in...



Korea's Anti-Rebate Laws Seen Sparking More Demand For MNC Products

SEOUL - Last week's passage of long-awaited "anti-rebate laws" that enable courts to punish both contributors and receivers of rebates, could trigger more demand from doctors to prescribe branded products from multinational companies, industry watchers said

Korea's Anti-Rebate Laws Seen Sparking More Demand For MNC Products

SEOUL - Last week's passage of long-awaited "anti-rebate laws" that enable courts to punish both contributors and receivers of rebates, could trigger more demand from doctors to prescribe branded products from multinational companies, industry watchers said

Leading Korean Pharma Companies Issued Fines In First Court Intervention Case Over Rebates

SEOUL - In the first court-involved case over rebates, three leading local South Korean pharma companies were issued stiff fines for "excessively unfair" business practices incurred by providing rebates to doctors and hospital

Related Content

UsernamePublicRestriction

Register

WI965023

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel